While weight loss is a common side effect of taking Ozempic , it is likely more helpful and advantageous to engage in diet and lifestyle changes first to try to lose weight before beginning medication
The weight-loss drug Wegovy lowered heart attack risk in a large trial Weekly injections of the medication cut the number of serious heart problems PHILADELPHIA At the recent American Heart Association meeting, a cavernous room full of doctors erupted into applause
With obesity rates in the UK now at very high levels, and associated with substantial multimorbidity, additional treatment options for sustained weight loss are greatly needed. Jason Murphy, the head of pharmacy at Chemist4U, said the announcement was a major step forward in treating obesity, increasing access and enabling millions more people to get treatment
[15] [37] [38] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
